Full text is available at the source.
Abstract
Oral incretin-based therapies are under review for treating overweight and obesity.
- The paper outlines the efficacy of emerging therapeutic candidates for weight management.
- Safety profiles of these therapies are evaluated alongside their effectiveness.
- Clinical recommendations are provided for the use of oral incretin-based therapies in managing overweight and obesity.
Simplified